

Author: Lorenc-Koci E. Wardas J. Bartoszyk G.D. Wolfarth S.
Publisher: Elsevier
ISSN: 0028-3908
Source: Neuropharmacology, Vol.45, Iss.8, 2003-12, pp. : 1057-1069
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content








By Bartoszyk G. D. van Amsterdam C. Greiner H. E. Rautenberg W. Russ H. Seyfried C. A.
Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. :


Combined 5-HT 1A and 5-HT 1B receptor agonists for the treatment of l-DOPA-induced dyskinesia
By Muñoz Ana
Brain, Vol. 131, Iss. 12, 2008-12 ,pp. :